Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19
Clinical trial NCT05676073 · COMPLETED
Trial details
- NCT number
- NCT05676073
- Sponsor
- Shenzhen Kexing Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-08
- Primary completion
- 2022-12-30
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.